Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Notes Payables (2016 - 2025)

Elevance Health (ELV) has disclosed Notes Payables for 17 consecutive years, with $150.0 million as the latest value for Q4 2025.

  • Quarterly Notes Payables fell 58.9% to $150.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $150.0 million through Dec 2025, down 58.9% year-over-year, with the annual reading at $150.0 million for FY2025, 58.9% down from the prior year.
  • Notes Payables for Q4 2025 was $150.0 million at Elevance Health, down from $180.0 million in the prior quarter.
  • The five-year high for Notes Payables was $1.6 billion in Q1 2024, with the low at $150.0 million in Q4 2025.
  • Average Notes Payables over 5 years is $323.6 million, with a median of $265.0 million recorded in 2022.
  • The sharpest move saw Notes Payables surged 494.34% in 2024, then crashed 84.13% in 2025.
  • Over 5 years, Notes Payables stood at $275.0 million in 2021, then fell by 3.64% to $265.0 million in 2022, then decreased by 15.09% to $225.0 million in 2023, then soared by 62.22% to $365.0 million in 2024, then crashed by 58.9% to $150.0 million in 2025.
  • According to Business Quant data, Notes Payables over the past three periods came in at $150.0 million, $180.0 million, and $360.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.